|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-8-23
|
|
pubmed:abstractText |
Pilsicainide is a newly synthesized antiarrhythmic agent with class Ic properties. Various antiarrhythmic agents have been used to convert atrial fibrillation (AF) to sinus rhythm or decrease the rate of relapse of AF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-8703
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
140
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e13
|
|
pubmed:meshHeading |
pubmed-meshheading:10966544-Administration, Oral,
pubmed-meshheading:10966544-Aged,
pubmed-meshheading:10966544-Anti-Arrhythmia Agents,
pubmed-meshheading:10966544-Atrial Fibrillation,
pubmed-meshheading:10966544-Chronic Disease,
pubmed-meshheading:10966544-Drug Administration Schedule,
pubmed-meshheading:10966544-Electric Countershock,
pubmed-meshheading:10966544-Female,
pubmed-meshheading:10966544-Heart Rate,
pubmed-meshheading:10966544-Humans,
pubmed-meshheading:10966544-Lidocaine,
pubmed-meshheading:10966544-Male,
pubmed-meshheading:10966544-Middle Aged,
pubmed-meshheading:10966544-Premedication,
pubmed-meshheading:10966544-Prognosis,
pubmed-meshheading:10966544-Recurrence,
pubmed-meshheading:10966544-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
|
|
pubmed:affiliation |
Department of Cardiology, Yokohama Red Cross Hospital, Yokohama-City, Japan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
